ClinicalTrials.govpublic full text
Acute Myeloid Leukemia Treated With With NETrin Abs in Combination With [AZACITIDINE + VENETOCLAX]
acute myeloid leukemia refractory, acute myeloid leukemia, unfit to intensive chemotherapy, np137, netrin-1, monoclonal antibody, azacitidine and venetoclax, refractory to azacitidine and venetoclax, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1031671
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.